This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA consultant Becky Davis was interviewed at Asembia AXS25 Summit to highlight her presentation titled “GLP-1s: Riding the Wave of Innovative Medications.”
Davis shared insights on navigating the evolving landscape of weight loss drugs, predicting market shifts and addressing insurance challenges. She highlighted the rising demand and expanding indications that are bringing GLP-1s into the spotlight.
Watch the interviews here: Pharmacy Times, Managed Healthcare Executive, and Drug Topics.
CRA consultant Becky Davis was interviewed by Managed Healthcare Executive at Asembia AXS25 Conference.
CRA consultant Becky Davis was interviewed by Drug Topics at Asembia AXS25 Conference on “Rising Demand, New Indications Put GLP-1s in the Spotlight.”
Hannah Armstrong moderates the session titled “Addressing Challenges with Access to Fertility Treatment and Preservation in APAC: Policy Recommendations for...
CRA is a proud sponsor of the conference that aims to increase the prominence of women through professional development, substantive legal discussion, and...
